LAnguage-Motor Imagery Circuits to Improve Motor Learning and Language Comprehension
NCT ID: NCT06478303
Last Updated: 2024-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
105 participants
OBSERVATIONAL
2024-07-27
2028-07-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motor Language Learning
NCT03223090
Decoding Motor Imagery From Non-invasive Brain Recordings as a Prerequisite for Innovative Motor Rehabilitation Therapies
NCT06469463
Motor Imagery in Aphantasia
NCT06140940
Language Acquisition in the Brain and Algorithms: Towards Systematic Monitoring of the Evolution of Semantic Representations in Biological and Artificial Neural Networks
NCT05217043
Neural Mechanisms of Motor and Cognitive Networks
NCT02828813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TMS Experimental group
Motor imagery
Participants were asked to imagine arm or foot movements.
Action reading
Participants were asked to read sentences involving arm or foot movements
fMRI Experimental group
Motor imagery
Participants were asked to imagine arm or foot movements.
Action reading
Participants were asked to read sentences involving arm or foot movements
Motor localizer
Participants were asked to perform arm or foot movements
Experimental ccPAS group
Motor imagery
Participants were asked to imagine arm or foot movements.
Action reading
Participants were asked to read sentences involving arm or foot movements
Sham ccPAS group
Motor imagery
Participants were asked to imagine arm or foot movements.
Action reading
Participants were asked to read sentences involving arm or foot movements
control group
Motor imagery
Participants were asked to imagine arm or foot movements.
Action reading
Participants were asked to read sentences involving arm or foot movements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motor imagery
Participants were asked to imagine arm or foot movements.
Action reading
Participants were asked to read sentences involving arm or foot movements
Motor localizer
Participants were asked to perform arm or foot movements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy subjects
* subjects reading and understanding French
* right-handed,
* affiliated with a social security system,
* between 18 and 40 years old,
* had completed the TMS inclusion questionnaire or had undergone a medical examination prior to participation in the MRI study.
Exclusion Criteria
* Regular use of anxiolytics, sedatives, antidepressants, neuroleptics,
* Characterized psychiatric pathology,
* Ingestion of alcohol prior to the examination,
* Persons covered by articles L1121-5 to L1121-8 of the CSP,
* Presence of contraindications to MRI or TMS.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Burgundy
OTHER
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurent VERCUEIL
Role: PRINCIPAL_INVESTIGATOR
CHU Grenoble Alpes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Grenoble Alpes
Grenoble, Grenob, France
Université de Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02322-43
Identifier Type: OTHER
Identifier Source: secondary_id
38RC23.0349
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.